Indapamide Eg (Indapamide)

Indapamide works by blocking the sodium‑chloride transporter in the distal convoluted tubule of the kidney, which reduces reabsorption of these ions. The resulting loss of sodium, chloride, and water lowers blood volume and peripheral resistance, leading to a decrease in blood pressure. It also has a mild vasodilatory effect.

The appropriate dose of Indapamide Eg is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

Indapamide is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus, but there are limited human data. It should be used during pregnancy only if clearly needed. Small amounts are excreted in breast milk, so breastfeeding mothers should discuss potential risks with their doctor.

To request Indapamide Eg, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action and a more favorable metabolic profile compared with traditional thiazides such as hydrochlorothiazide. It provides effective blood‑pressure reduction with a lower incidence of electrolyte disturbances, making it a preferred option for many clinicians.

Indapamide Eg tablets should be stored at temperatures below 25 °C, in their original packaging, protected from moisture, heat and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

Indapamide Eg is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber. Patients should swallow the tablet whole and avoid crushing or chewing it unless specifically instructed.

Serious risks include severe dehydration, acute kidney injury, and rare allergic reactions such as rash, swelling or difficulty breathing. Electrolyte imbalances, particularly low potassium, can also lead to cardiac arrhythmias. Patients should report any sudden weakness, dizziness, or swelling to their healthcare provider promptly.

Indapamide Eg should be avoided in patients with known hypersensitivity to indapamide or other sulfonamide drugs, in those with severe liver disease, and in individuals with uncontrolled electrolyte disturbances. Caution is also advised for patients with severe renal impairment or those taking interacting medications such as lithium or NSAIDs.